We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$487M
AUM Growth
+$60.8M
Cap. Flow
+$38.3M
Cap. Flow %
7.87%
Top 10 Hldgs %
34.77%
Holding
122
New
17
Increased
29
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$7.16M
2
ABT icon
Abbott
ABT
+$4.51M
3
DUK icon
Duke Energy
DUK
+$3.52M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.16M
5
SCG
Scana
SCG
+$2.45M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$2.45M
2
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$2.24M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.46M
4
GSK icon
GSK
GSK
+$497K
5
AMAT icon
Applied Materials
AMAT
+$423K

Sector Composition

Rank Sector Weight
1 Healthcare 27.69%
2 Industrials 18.44%
3 Technology 17.48%
4 Utilities 8.95%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
26
Exelon
EXC
$48.6B
$6.24M 1.28%
240,415
-7,010
-3% -$173K
NEE icon
27
NextEra Energy
NEE
$187B
$6.09M 1.25%
186,940
-2,400
-1% -$72.1K
MSFT icon
28
Microsoft
MSFT
$2.84T
$5.78M 1.19%
112,867
-2,150
-2% -$112K
ABT icon
29
Abbott
ABT
$180B
$5.73M 1.18%
145,871
+113,373
+349% +$4.51M
ADM icon
30
Archer Daniels Midland
ADM
$41.4B
$5.51M 1.13%
128,500
-1,700
-1% -$67.8K
OGE icon
31
OGE Energy
OGE
$10.3B
$5.31M 1.09%
162,085
+200
+0.1% +$5.99K
IDA icon
32
Idacorp
IDA
$8.23B
$5.28M 1.09%
64,960
-1,050
-2% -$77.4K
MDU icon
33
MDU Resources
MDU
$4.44B
$5.12M 1.05%
561,152
-17,883
-3% -$146K
WTS icon
34
Watts Water Technologies
WTS
$11.5B
$4.75M 0.97%
81,475
+18,000
+28% +$1.02M
EMC
35
DELISTED
EMC CORPORATION
EMC
$4.68M 0.96%
172,200
-3,575
-2% -$96.6K
MDT icon
36
Medtronic
MDT
$107B
$4.67M 0.96%
53,825
-1,531
-3% -$124K
MON
37
DELISTED
Monsanto Co
MON
$4.66M 0.96%
45,090
+2,000
+5% +$198K
LGTY
38
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$4.29M 0.88%
409,355
+42,240
+12% +$397K
CHMG icon
39
Chemung Financial Corp
CHMG
$390M
$4.26M 0.87%
145,132
+26,949
+23% +$774K
TMO icon
40
Thermo Fisher Scientific
TMO
$211B
$4.21M 0.86%
28,492
-334
-1% -$49.3K
BNS icon
41
Scotiabank
BNS
$106B
$4.15M 0.85%
84,600
+37,382
+79% +$1.84M
LFCR icon
42
Lifecore Biomedical
LFCR
$162M
$4.14M 0.85%
384,825
+87,425
+29% +$964K
DGX icon
43
Quest Diagnostics
DGX
$25.1B
$4.07M 0.84%
49,986
+46
+0.1% +$3.5K
NVS icon
44
Novartis
NVS
$295B
$3.96M 0.81%
53,623
-613
-1% -$42.4K
MMM icon
45
3M
MMM
$89B
$3.51M 0.72%
23,948
-471
-2% -$66.4K
HLIO icon
46
Helios Technologies
HLIO
$2.64B
$3.43M 0.71%
115,625
+3,700
+3% +$117K
CGW icon
47
Invesco S&P Global Water Index ETF
CGW
$1.05B
$3.4M 0.7%
113,550
-1,800
-2% -$52.3K
PEG icon
48
Public Service Enterprise Group
PEG
$39.8B
$3.37M 0.69%
72,360
-3,600
-5% -$163K
HAL icon
49
Halliburton
HAL
$27.9B
$3.33M 0.68%
73,634
-200
-0.3% -$8.23K
CIEN icon
50
Ciena
CIEN
$55.3B
$3.2M 0.66%
170,500
+91,000
+114% +$1.65M
1
2
3 4 5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return

John G. Ullman & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, John G. Ullman & Associates held 122 positions worth $487M, up 14% from $426M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

John G. Ullman & Associates deployed $38.3M of net new capital in Q2 2016, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.46M trimmed.

  • John G. Ullman & Associates's largest Q2 2016 buy was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.
  • John G. Ullman & Associates added most to TE Connectivity in Q2 2016, an estimated $7.16M increase.
  • John G. Ullman & Associates's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $1.46M.
  • John G. Ullman & Associates fully exited Booking.com in Q2 2016, selling an estimated $2.45M.
  • John G. Ullman & Associates's ten largest holdings make up 35% of its $487M portfolio in Q2 2016.
  • John G. Ullman & Associates opened 17 new positions and closed 5 in Q2 2016.
  • John G. Ullman & Associates's portfolio value rose 14% quarter-over-quarter to $487M.

Based on John G. Ullman & Associates's 13F filing for Q2 2016, filed 22 Jul 2016.